Provided by Tiger Trade Technology Pte. Ltd.

First Wave BioPharma, Inc.

2.96
0.0000
Volume:- -
Turnover:167.47K
Market Cap:5.99M
PE:-0.34
High:2.96
Open:2.96
Low:2.96
Close:2.96
52wk High:62.40
52wk Low:2.33
Shares:2.03M
Float Shares:1.91M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.6107
EPS(LYR):-47.8772
ROE:-497.87%
ROA:-159.97%
PB:1.66
PE(LYR):-0.06

Loading ...

May 16, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 16, 2024

Correspondence

Form CORRESP - Correspondence
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 27, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 27, 2023

Major Issues Report

Form 8-K - Current report
Dec 27, 2023

Major Issues Report

Form 8-K - Current report
Dec 18, 2023

Major Issues Report

Form 8-K - Current report
Dec 18, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933